Adverse Event Reporting Gilead Oncology | GileadPro

For UK healthcare professionals only. This page contains promotional content
Adverse Event Reporting Prescribing information

Adverse events should be reported.

For the UK, reporting forms and information can be found at www.mhra.gov.uk/yellowcard or via the Yellow Card app (download from the Apple App Store or Google Play Store). Adverse events should also be reported to Gilead to [email protected] or ‌+‌4‌4‌ ‌(‌0‌)‌ ‌1‌2‌2‌3‌ ‌8‌9‌7‌5‌0‌0‌.‌

TRODELVY®▼ (sacituzumab govitecan) Prescribing information for UK

Trodelvy® Summary of Product Characteristics (UK). Gilead Sciences Ltd. Available at: https://www.medicines.org.uk/emc/product/12880. Accessed: February 2025.

UKI-TRO-0165 February 2025

Adverse events should be reported

For the UK, reporting forms and information can be found at www.mhra.gov.uk/yellowcard or via the Yellow Card app (download from the Apple App Store or Google Play Store). Adverse events should also be reported to Gilead to [email protected] or +44 (0) 1223 897500.